There have been 48 recent insider transactions recorded for BeOne Medicines Ltd. (ONC), including 14 buys and 31 sells. Total insider buying was valued at $20.15M and total insider selling at $21.34M.
Notable insiders with recent activity include Lee Chan Henry, Oyler John, Wu Xiaobin. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — ONC
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-11 |
Lee Chan Henry |
SVP, General Counsel |
Informative Sell |
341 |
$300.00 |
$102.3K |
- |
| 2026-03-06 |
Oyler John |
Chief Executive Officer |
RSU Award |
326,976 |
- |
- |
5,491,339 |
| 2026-03-06 |
Wu Xiaobin |
President and COO |
RSU Award |
168,922 |
- |
- |
1,137,900 |
| 2026-03-06 |
Wang Lai |
President, Global Head of R&d |
RSU Award |
112,606 |
- |
- |
1,564,030 |
| 2026-03-06 |
Lee Chan Henry |
SVP, General Counsel |
RSU Award |
65,390 |
- |
- |
288,496 |
| 2026-03-06 |
Rosenberg Aaron |
Chief Financial Officer |
RSU Award |
79,014 |
- |
- |
294,346 |
| 2026-02-04 |
Lee Chan Henry |
SVP, General Counsel |
Informative Sell |
996 |
$350.00 |
$348.6K |
- |
| 2026-01-07 |
Lee Chan Henry |
SVP, General Counsel |
Informative Sell |
664 |
$331.76 |
$220.29K |
- |
| 2025-12-31 |
Wang Lai |
President, Global Head of R&d |
RSU Award |
427,895 |
- |
- |
1,451,424 |
| 2025-12-16 |
Oyler John |
Chief Executive Officer |
Informative Sell |
40 |
$305.24 |
$12.21K |
- |
| 2025-12-15 |
Oyler John |
Chief Executive Officer |
Informative Sell |
1,194 |
$314.92 |
$376.01K |
24,369 |
| 2025-12-11 |
Lee Chan Henry |
SVP, General Counsel |
Informative Sell |
332 |
$325.00 |
$107.9K |
- |
| 2025-12-10 |
Lee Chan Henry |
SVP, General Counsel |
Informative Sell |
332 |
$318.28 |
$105.67K |
- |
| 2025-11-26 |
Sanders Corazon (corsee) D. |
Director |
Informative Sell |
804 |
$342.47 |
$275.35K |
- |
| 2025-11-17 |
Wu Xiaobin |
President and COO |
Informative Sell |
10 |
$382.32 |
$3.82K |
- |
| 2025-11-13 |
Wu Xiaobin |
President and COO |
Informative Sell |
1,769 |
$381.05 |
$674.08K |
- |
| 2025-11-12 |
Oyler John |
Chief Executive Officer |
Gift (Given) |
858,533 |
- |
- |
6,441,041 |
| 2025-11-12 |
Wu Xiaobin |
President and COO |
Informative Sell |
154 |
$362.07 |
$55.76K |
6,009 |
| 2025-11-12 |
Lee Chan Henry |
SVP, General Counsel |
Informative Sell |
332 |
$350.00 |
$116.2K |
- |
| 2025-11-11 |
Oyler John |
Chief Executive Officer |
Gift (Given) |
151,320 |
- |
- |
7,299,574 |
| 2025-11-07 |
Wang Xiaodong |
Other: Chair, Scientific Advisory Brd |
Gift (Given) |
424,073 |
- |
- |
4,582,601 |
| 2025-10-08 |
Lee Chan Henry |
SVP, General Counsel |
Option Exercise |
296 |
$159.03 |
$47.07K |
9,559 |
| 2025-06-24 |
Wang Xiaodong |
Other: Chair, Scientific Advisory Brd |
Informative Sell |
100 |
$267.81 |
$26.78K |
- |
| 2025-06-23 |
Oyler John |
Chief Executive Officer |
Informative Sell |
100 |
$262.90 |
$26.29K |
- |
| 2025-06-23 |
Wu Xiaobin |
President and COO |
Informative Sell |
1,363 |
$260.00 |
$354.38K |
- |
| 2025-06-23 |
Wang Lai |
Global Head of R&d |
Informative Sell |
1,028 |
$260.00 |
$267.28K |
- |
| 2025-06-17 |
Oyler John |
Chief Executive Officer |
Informative Sell |
1,460 |
$256.49 |
$374.47K |
- |
| 2025-06-17 |
Wu Xiaobin |
President and COO |
Informative Sell |
630 |
$250.87 |
$158.05K |
- |
| 2025-06-17 |
Wang Lai |
Global Head of R&d |
Informative Sell |
470 |
$251.37 |
$118.14K |
- |
| 2025-06-16 |
Oyler John |
Chief Executive Officer |
Informative Sell |
3,680 |
$266.05 |
$979.05K |
1,460 |
| 2025-06-16 |
Wu Xiaobin |
President and COO |
Informative Sell |
100 |
$266.22 |
$26.62K |
630 |
| 2025-06-16 |
Wang Lai |
Global Head of R&d |
Informative Sell |
1,177 |
$266.40 |
$313.56K |
470 |
| 2025-06-16 |
Lee Chan Henry |
SVP, General Counsel |
Informative Sell |
422 |
$266.50 |
$112.46K |
- |
| 2025-06-11 |
Ball Titus B. |
Principal Accounting Officer |
Informative Sell |
134 |
$258.36 |
$34.62K |
- |
| 2025-06-10 |
Oyler John |
Chief Executive Officer |
RSU Award |
348,374 |
$20.26 |
$7.06M |
348,374 |
| 2025-06-10 |
Yi Qingqing |
Director |
Other (Sell) |
29,614 |
- |
- |
27,326 |
| 2025-06-10 |
Wang Xiaodong |
Other: Chair, Scientific Advisory Brd |
Informative Sell |
100 |
$264.85 |
$26.49K |
- |
| 2025-06-10 |
Ball Titus B. |
Principal Accounting Officer |
RSU Award |
29,601 |
- |
- |
73,983 |
| 2025-06-10 |
Wu Xiaobin |
President and COO |
RSU Award |
232,245 |
$20.26 |
$4.71M |
232,245 |
| 2025-06-10 |
Wang Lai |
Global Head of R&d |
RSU Award |
162,565 |
$20.26 |
$3.29M |
162,565 |
| 2025-06-10 |
Lee Chan Henry |
SVP, General Counsel |
RSU Award |
88,244 |
$20.26 |
$1.79M |
88,244 |
| 2025-06-10 |
Rosenberg Aaron |
Chief Financial Officer |
RSU Award |
119,873 |
$20.26 |
$2.43M |
119,873 |
| 2025-06-06 |
Oyler John |
Chief Executive Officer |
Informative Sell |
400 |
$255.74 |
$102.3K |
- |
| 2025-06-06 |
Wu Xiaobin |
President and COO |
Informative Sell |
234 |
$255.77 |
$59.85K |
- |
| 2025-06-06 |
Wang Lai |
Global Head of R&d |
Informative Sell |
300 |
$255.30 |
$76.59K |
- |
| 2025-06-06 |
Lee Chan Henry |
SVP, General Counsel |
Informative Sell |
230 |
$256.79 |
$59.06K |
- |
| 2025-05-21 |
Baker Bros. Advisors Lp |
Director |
RSU Award |
45,500 |
$18.19 |
$827.65K |
45,500 |
| 2025-02-28 |
Baker Bros. Advisors Lp |
Director |
Informative Sell |
60,851 |
$260.00 |
$15.82M |
730,642 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
